Mark Nedelman, President & CEO since 2010, has over 20 years experience in both contract research and pharmaceutical firms. Over a 10 year period, Mark built Primedica Corporation’s Pharmacology and Experimental Surgery program to $18MM in revenue and led the Interventional and Surgical Services Group at Charles River Laboratories to $26MM annual revenue. Earlier in his career, he led preclinical development efforts on several first-in-class drugs at Centocor.

Craig Ferris, PhD, CSO and Co-Founder, is a professor of Psychology and Pharmaceutical Sciences at Northeastern University and Director of its Center for Translational Neuroimaging (CTNI). Prior to his appointments at Northeastern, he was Professor of Psychiatry and Physiology and Director of the Center for Comparative Neuroimaging at the University of Massachusetts Medical School.

Praveen Kulkarni, PhD, Co-Founder, is a Senior Research Scientist at Center for Translational Neuroimaging (CTNI).